Compare PAR & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAR | RAPP |
|---|---|---|
| Founded | 1968 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2024 |
| Metric | PAR | RAPP |
|---|---|---|
| Price | $21.53 | $25.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $64.00 | $47.00 |
| AVG Volume (30 Days) | ★ 1.4M | 349.6K |
| Earning Date | 02-27-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $440,451,000.00 | N/A |
| Revenue This Year | $30.39 | N/A |
| Revenue Next Year | $11.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 39.88 | N/A |
| 52 Week Low | $22.03 | $6.43 |
| 52 Week High | $72.60 | $42.27 |
| Indicator | PAR | RAPP |
|---|---|---|
| Relative Strength Index (RSI) | 20.18 | 41.56 |
| Support Level | $27.35 | $25.32 |
| Resistance Level | $40.54 | $28.59 |
| Average True Range (ATR) | 1.98 | 1.55 |
| MACD | -1.17 | -0.03 |
| Stochastic Oscillator | 0.35 | 14.79 |
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.